ライフサイエンスコーパス: basal secretion

1 ptake, they do not enhance pulse velocity or basal secretion.

2 69 nmol/l are considered to represent normal basal secretion.

3 m-tomosyn-2 was novel in strongly augmenting basal secretion.

4 he inhibitory effects on stimulated, but not basal, secretion.

5 mature secretory granules, with no effect on basal secretion; a cell-permeant control peptide (Kal-C-

6 rovide a foundation for defining pathways of basal secretion and AASIS, augmenting our understanding

7 lycemia, indicating the importance of GDH in basal secretion and AASIS.

8 Compared with their basal secretion at 5 mM glucose, cysts/cultivated human

9 The somatostatin antibody increased basal secretion by 4-fold in wild-type and had no effect

10 nd to regulate angiotensin II-stimulated and basal secretion, expression and promoter activity of BNP

11 o 11.1 mM glucose by 67%, but did not affect basal secretion in 2.8 mM glucose.

12 cretion in wild-type mice, but did not alter basal secretion in knockout mice.

13 ng Cdc42 in an inactive state and regulating basal secretion in the absence of stimuli.

14 antation may be due to increased less potent basal secretion in the fasting state and less frequent,

15 We conclude that in awake rats, PP inhibits basal secretion, in part, through the AP.

16 of endocrine pituitary cells regulates their basal secretion level.

17 Basal secretion of 17-OH-progesterone, 11-deoxycortisol,

18 Basal secretion of beta-endorphin was first observed at

19 lization of Munc18c, which normally prevents basal secretion of digestive enzymes.

20 palmitate levels to simultaneously increase basal secretion of glucagon and insulin positions elevat

21 on of PKA activity caused an increase in the basal secretion of GnRH.

22 atinocytes, EPA and DHA were shown to reduce basal secretion of IL-8 by 66% and 63%, respectively (p<

23 d sharply reduces pulmonary eosinophilia and basal secretion of MC products.

24 Basal secretion of serum corticosterone was not distingu

25 Depleting cellular copper stimulates basal secretion of soluble enzyme produced by endoproteo

26 data using intact GH3 cells demonstrate that basal secretion of SRIF-related material is largely calc

27 PS stimulation, but no evidence of increased basal secretion of these cytokines, or alterations in ba

28 "Basal" secretion of 0.7 +/- 0.1 nl x min(-1) gland(-1) w

29 ic Ca(2+) signaling that helps determine the basal secretion rate and stringency of COPII-dependent c

30 181+/-8 microg (n=26, mean +/- S.E.M.), and basal secretion rate, 4.4+/-0.4 microg h(-1), indicated

31 flammatory agents was inhibited, but not the basal secretion rate.

32 to 1 mmol/L glucose, resulting in very high basal secretion rates that were inhibited by diazoxide a

33 f duodenal HCO(3)(-) secretion proposes that basal secretion results from Cl(-)/HCO(3)(-) exchange, w

34 ffusion hypothesis, auxin pulse velocity and basal secretion should increase with decreasing cell wal

35 der 5 conditions: unstimulated (to determine basal secretion), stimulated with forskolin, stimulated

36 Both agents inhibit basal secretion via a histamine-independent and neurally

37 t the overexpressed PKCalpha was active, and basal secretion was increased.

38 ed vWF secretion was reduced by 40%, whereas basal secretion was unchanged.

39 d protein secretion was not stimulated above basal secretion, whereas alpha1-adrenergic-agonist-stimu

40 sed 2-3-fold above the already high level of basal secretion, whereas lysosomal SMase activity was de